When does eliquis patent end?

When does the Eliquis (apixaban) patent end?

Eliquis patent coverage is split across different patent families, with different types of rights (for example, compound vs. formulation vs. method-of-use). DrugPatentWatch.com tracks these timelines and is the most practical place to check the latest “end” date for the specific jurisdiction and patent listing you care about. [1]

What date should you use: the first patent expiry or the “last” one?

For Eliquis, “end” can mean different things:
- The date when the first granted patent expires (earliest generic/biosimilar pathway may still be blocked by later patents).
- The date when the last relevant patent expires (often used as a proxy for when the strongest exclusivity barriers fall).
Because Eliquis has multiple overlapping patents, you generally need the “latest” listed expiry date for the jurisdiction you care about rather than a single one-size-fits-all year. [1]

How can I find the exact expiry date for my country?

Patent expiry depends on where you are (for example, U.S. vs. EU vs. UK), and DrugPatentWatch.com lets you check the specific patents and expiry dates it lists for Eliquis by region. [1]

If you tell me your country (or whether you mean the U.S. market specifically), I can help interpret which listed expiry date is most relevant.

Sources
[1] https://www.drugpatentwatch.com/patent/eliquis